Rapport Therapeutics, Inc. (RAPP) stock
Close on Nov 12, 2026Market cap $1.24BP/E –Yield –
Rapport Therapeutics statistics
61 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 9, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 3.17
- 2.29
Share statisticsIndustry
- Shares Change (YoY)
- 31.8%
- 10.9%
- Shares Change (QoQ)
- 0.28%
- 0.51%
- Float
- 23M
- 49M
- Shares Held by Insiders
- 51.3%
- 12.1%
- Shares Held by Institutions
- 106.9%
- 56.4%
Short sellingIndustry
- Short Interest
- 4M
- –
- Short Interest Change
- 29.7%
- -0.76%
- Short % of Float
- 16.9%
- 9.04%
- Short % of Shares Outstanding
- 8.25%
- 6.30%
- Days to Cover
- 1.79
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $52.93
- –
- 52-Week Low
- $22.06
- –
- 20-Day Moving Average
- $25.86
- –
- 50-Day Moving Average
- $32.36
- –
- 200-Day Moving Average
- $35.59
- –
- Average True Range (14)
- $2.17
- –
- Price Change (1 Week)
- 8.98%
- 1.51%
- Price Change (1 Month)
- -8.75%
- -2.35%
- Price Change (3 Months)
- -45.5%
- -21.1%
- Price Change (6 Months)
- -31.9%
- -22.6%
- Price Change (YTD)
- -14.8%
- -22.6%
- Price Change (1 Year)
- 1.37%
- -20.7%
- Average Volume (10 Days)
- 825,790
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 637,437
- –
- Relative Volume
- 0.89
- 0.79
- Relative Strength Index (14)
- 43.8
- 44.7
- Volatility (1 Year)
- 62.3%
- 80.4%
- Beta (5 Years)
- 1.74
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -33.3%
- -51.2%
- Return on Assets (ROA)
- -31.5%
- -40.6%
- Return on Capital Employed (ROCE)
- -42.1%
- -38.0%
Financial positionIndustry
- Current Ratio
- 20.07
- 3.30
- Quick Ratio
- 19.46
- 2.42
EfficiencyIndustry
- Profits Per Employee
- -$1.79M
- -$683.67K
- Employee Count
- 84
- 75
- WACC
- 13.7%
- 10.1%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $395.00M
- $17.46M
- Net Cash Per Share
- $8.23
- $0.72
- Equity (Book Value)
- $391.19M
- $53.27M
- Book Value Per Share
- $8.15
- $1.50
- Tangible Book Value
- $391.19M
- $26.82M
- Working Capital
- $387.08M
- $79.47M
Cash flow (TTM)Industry
- Capital Expenditures
- -$333.00K
- -$944.00K
- FCF Per Share
- -$2.53
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -12.1%
- -20.8%
- FCF Yield
- -9.77%
- -9.58%
Scores and fair valueIndustry
- Altman Z-Score
- 25.80
- 0.30
- Piotroski F-Score
- 3
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | RAPP | S&P 500 | Difference | RAPP per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -14.3% | -2.7% | −11.6 pts | ||
| 3 months | -45.8% | -1.7% | −44.1 pts | ||
| Year to date | -14.8% | +11.9% | −26.7 pts | ||
| 1 year | +2.7% | +12.0% | −9.3 pts | ||
| 3 years | +1623.3% | +78.2% | +1545.2 pts | +158.3% | +21.2% |
| 5 years | +1623.3% | +73.2% | +1550.1 pts | +76.7% | +11.6% |
| 10 years | +1623.3% | +309.6% | +1313.7 pts | +32.9% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
4M RAPP shares were sold short on Oct 30, 2026, up 29.7% from the previous report, or 16.92% of the shares available to trade. At recent volumes it would take 1.8 days to buy them back. Over the last 20 sessions, 58.1% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 3,956,396 | +29.7% | 2,214,106 | 1.8 |
| Oct 15, 2026 | 3,051,500 | -4.5% | 259,510 | 11.8 |
| Sep 30, 2026 | 3,194,008 | +42.1% | 660,098 | 4.8 |
| Sep 15, 2026 | 2,248,069 | +0.6% | 284,289 | 7.9 |
| Aug 31, 2026 | 2,233,723 | +0.4% | 271,423 | 8.2 |
| Aug 14, 2026 | 2,225,618 | -1.0% | 295,758 | 7.5 |
| Jul 31, 2026 | 2,248,235 | -16.4% | 299,167 | 7.5 |
| Jul 15, 2026 | 2,690,734 | +19.1% | 438,999 | 6.1 |
| Jun 30, 2026 | 2,260,158 | +0.6% | 488,981 | 4.6 |
| Jun 15, 2026 | 2,246,097 | -8.7% | 316,690 | 7.1 |
| May 29, 2026 | 2,459,901 | +1.8% | 284,811 | 8.6 |
| May 15, 2026 | 2,417,349 | -20.7% | 348,797 | 6.9 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?